Eric Dane Reveals ALS Diagnosis, Rebecca Gayheart Shares Early Signs

Key Points

• Actor Eric Dane confirmed in April 2025 that he has been diagnosed with ALS (Lou Gehrig’s disease).
• ALS is a progressive neurodegenerative condition that affects nerve cells in the brain and spinal cord.
• Dane’s ex-wife, actress Rebecca Gayheart, revealed he first noticed symptoms about a year before his official diagnosis.
• The news has sparked widespread support from fans and colleagues across Hollywood.
• Dane is best known for his roles in Grey’s Anatomy and Euphoria.

Diagnosis Confirmed in April

Actor Eric Dane, widely recognized for his role as Dr. Mark Sloan on Grey’s Anatomy, announced in April 2025 that he has been diagnosed with ALS, also known as Lou Gehrig’s disease. The condition gradually weakens muscles and impacts physical function, with no known cure.

Rebecca Gayheart Speaks Out

Dane’s ex-wife, actress Rebecca Gayheart, has shed light on the timeline leading up to his diagnosis. According to Gayheart, Dane began noticing troubling symptoms nearly a year before doctors confirmed ALS. She explained that subtle changes in his health raised concerns, eventually leading to medical testing and the diagnosis.

Career and Legacy

Dane rose to fame on Grey’s Anatomy and later starred in HBO’s Euphoria, where he played Cal Jacobs. His career has spanned both television and film, making him a familiar face to audiences worldwide. The announcement of his illness has prompted an outpouring of support from fans and industry peers.

Context: Why It Matters

ALS has affected several public figures over the years, drawing attention to the need for continued research and awareness. Dane’s openness about his condition highlights the importance of early detection and the challenges faced by those living with the disease.

What Happens Next?

Dane is expected to focus on his health while continuing to receive support from family, friends, and fans. Advocacy groups anticipate his diagnosis will help raise awareness and funding for ALS research, keeping the conversation active in both Hollywood and the wider public sphere.